Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.

In just the fourth quarter of its 2022 fiscal year, ResMed raked in between $60 million and $70 million in CPAP sales directly related to the gap left by the Philips recall, the company said. (ResMed) ...

TORONTO, ON / ACCESSWIRE / November 6, 2024 / Air Voel, a leading provider of CPAP solutions in Canada, is proud to announce the expansion of its product line with the latest CPAP machines from ResMed ...

When do medical device companies sound like parents proudly touting how their toddlers eat vegetables? When they can demonstrate that thousands of patients are adhering to a difficult therapy using ...

Loud snoring at night. Pauses in breathing followed by gasps for air while you're asleep. Excessive daytime fatigue. Frequent nodding off in front of the TV or even when behind the wheel of a ...

ResMed (RMD) shares fell in the premarket on Wednesday after Morgan Stanley downgraded the respiratory device maker, citing headwinds from the GLP-1 class of weight-loss drugs and a potential re-entry ...

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...

CPAP — continuous positive airway pressure — machines help people with sleep apnea breathe more regularly through the night. These machines are also sometimes used by first responders to help people ...

GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...